JP2013136631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013136631A5 JP2013136631A5 JP2013055494A JP2013055494A JP2013136631A5 JP 2013136631 A5 JP2013136631 A5 JP 2013136631A5 JP 2013055494 A JP2013055494 A JP 2013055494A JP 2013055494 A JP2013055494 A JP 2013055494A JP 2013136631 A5 JP2013136631 A5 JP 2013136631A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- aryl
- compound
- deoxorapamycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0601406.2A GB0601406D0 (en) | 2006-01-24 | 2006-01-24 | Organic Compounds |
| GB0601406.2 | 2006-01-24 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008551707A Division JP5416412B2 (ja) | 2006-01-24 | 2007-01-22 | ラパマイシン誘導体の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013136631A JP2013136631A (ja) | 2013-07-11 |
| JP2013136631A5 true JP2013136631A5 (https=) | 2013-10-03 |
Family
ID=36060760
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008551707A Expired - Fee Related JP5416412B2 (ja) | 2006-01-24 | 2007-01-22 | ラパマイシン誘導体の製造方法 |
| JP2013055494A Pending JP2013136631A (ja) | 2006-01-24 | 2013-03-18 | ラパマイシン誘導体の製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008551707A Expired - Fee Related JP5416412B2 (ja) | 2006-01-24 | 2007-01-22 | ラパマイシン誘導体の製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8138344B2 (https=) |
| EP (1) | EP1979359A1 (https=) |
| JP (2) | JP5416412B2 (https=) |
| KR (1) | KR101423343B1 (https=) |
| CN (2) | CN104211716A (https=) |
| AU (1) | AU2007209569B2 (https=) |
| BR (1) | BRPI0707330A2 (https=) |
| CA (1) | CA2637075A1 (https=) |
| GB (1) | GB0601406D0 (https=) |
| RU (1) | RU2448970C2 (https=) |
| WO (1) | WO2007085400A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0601406D0 (en) * | 2006-01-24 | 2006-03-08 | Novartis Ag | Organic Compounds |
| US9876615B2 (en) * | 2012-11-13 | 2018-01-23 | Lg Electronics Inc. | Method and apparatus for transmitting and receiving data multiple times in consecutive subframes |
| ES2897473T3 (es) | 2013-03-15 | 2022-03-01 | Biosensors Int Group Ltd | Purificación de derivados de la rapamicina |
| EP3109250A1 (en) * | 2015-06-23 | 2016-12-28 | Synbias Pharma AG | Method for the synthesis of rapamycin derivatives |
| AR112834A1 (es) | 2017-09-26 | 2019-12-18 | Novartis Ag | Derivados de rapamicina |
| MX2021007247A (es) | 2018-12-18 | 2021-07-15 | Novartis Ag | Derivados de rapamicina. |
| EP3914245A4 (en) | 2019-01-22 | 2022-08-24 | Aeovian Pharmaceuticals, Inc. | MTORC-1 MODULATORS AND USES THEREOF |
| WO2021195599A1 (en) * | 2020-03-27 | 2021-09-30 | Aeovian Pharmaceuticals, Inc. | Mtorc1 modulators and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256790A (en) * | 1992-08-13 | 1993-10-26 | American Home Products Corporation | 27-hydroxyrapamycin and derivatives thereof |
| GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| EP0833828B1 (en) | 1995-06-09 | 2002-11-20 | Novartis AG | Rapamycin derivatives |
| WO2001051919A2 (en) * | 2000-01-07 | 2001-07-19 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
| GB0601406D0 (en) * | 2006-01-24 | 2006-03-08 | Novartis Ag | Organic Compounds |
-
2006
- 2006-01-24 GB GBGB0601406.2A patent/GB0601406D0/en not_active Ceased
-
2007
- 2007-01-22 EP EP07702931A patent/EP1979359A1/en not_active Withdrawn
- 2007-01-22 KR KR1020087018088A patent/KR101423343B1/ko not_active Expired - Fee Related
- 2007-01-22 JP JP2008551707A patent/JP5416412B2/ja not_active Expired - Fee Related
- 2007-01-22 CN CN201410391783.0A patent/CN104211716A/zh active Pending
- 2007-01-22 CA CA002637075A patent/CA2637075A1/en not_active Abandoned
- 2007-01-22 US US12/160,110 patent/US8138344B2/en not_active Expired - Fee Related
- 2007-01-22 RU RU2008134424/04A patent/RU2448970C2/ru not_active IP Right Cessation
- 2007-01-22 CN CNA2007800034190A patent/CN101374847A/zh active Pending
- 2007-01-22 AU AU2007209569A patent/AU2007209569B2/en not_active Ceased
- 2007-01-22 WO PCT/EP2007/000514 patent/WO2007085400A1/en not_active Ceased
- 2007-01-22 BR BRPI0707330-5A patent/BRPI0707330A2/pt not_active IP Right Cessation
-
2013
- 2013-03-18 JP JP2013055494A patent/JP2013136631A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013136631A5 (https=) | ||
| JP2019524861A5 (https=) | ||
| JP2010535722A5 (https=) | ||
| EP4458348A3 (en) | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof | |
| SI2906563T1 (en) | Derivatives of pyrrolo (3,2-d) pyrimidine for the treatment of viral infections and other diseases | |
| MY192109A (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| EP4424314A3 (en) | Substituted polycyclic pyridone derivative and prodrug thereof | |
| JP2017508789A5 (https=) | ||
| AR067413A1 (es) | Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer | |
| RU2017120970A (ru) | Производные желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения | |
| PE20141205A1 (es) | Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores de bace1 y/o bace2 | |
| JP2014506599A5 (https=) | ||
| NZ708801A (en) | Aryl and heteroaryl fused lactams | |
| NZ599040A (en) | 2,4-disubstituted pyrido[4,3-d]pyrimidin-5(6h)-one compounds for selective inhibitors of lrrk2 and syk kinases | |
| RU2013151803A (ru) | Бициклические гетероциклические соединения и их применения в терапии | |
| PH12015501226A1 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same | |
| JP2015520140A5 (https=) | ||
| AR085489A1 (es) | Derivados de triazolopiridinas, composiciones farmaceuticas que los contienen, proceso para prepararlos, intermediarios de dicho proceso y uso de los mismos para el tratamiento de enfermedades autoinmunes e inflamatorias | |
| AR080596A1 (es) | Compuestos alquilamido y composiciones farmaceuticas | |
| RU2013126531A (ru) | Селективные ингибиторы гликозидазы и их применение | |
| PH12017501652A1 (en) | Kv1.3 inhibitors and their medical application | |
| TR201902080T4 (tr) | N-asil-(3-sübstitüe)-(8-sübstitüe)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinlerinin yeni kiral sentezleri. | |
| RU2008134424A (ru) | Способ получения производных рапамицина | |
| PH12017501655B1 (en) | Morphinan derivative | |
| AR044511A1 (es) | Procedimiento para resolver triazinas utilizadas en el tratamiento de sindrome de resistencia a la insulina |